Prolong Super Lubricants offers a new premium diesel engine oil featuring the company's proprietary Anti-Friction Metal Treatment (AFMT). According to the company, this advanced technology bonds to ...

WALTHAM, Mass., March 08, 2019 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) announced today topline results from PROLONG (Progestin's Role in Optimizing Neonatal Gestation), a ...

Prolong(r) Super Lubricants offers its industry-leading Engine Treatment and Booster System to protect gas and diesel engines from the two leading causes of engine wear: damaging friction and heat.

SOUTH PLAINFIELD, N.J.--(BUSINESS WIRE)--Prolong Pharmaceuticals, LLC (the Company), a clinical-stage biopharmaceutical company, announced that it will present new clinical data from HEMERA-1 (Phase 1 ...

SOUTH PLAINFIELD, N.J.--(BUSINESS WIRE)--Prolong Pharmaceuticals, LLC (the Company), a clinical-stage biopharmaceutical company, announced that the Company will deliver two oral presentations, an oral ...

SOUTH PLAINFIELD, N.J., Dec. 18, 2013 /PRNewswire/ -- Prolong Pharmaceuticals LLC, a biopharmaceutical company dedicated to developing products to treat several diseases and their debilitating ...

SOUTH PLAINFIELD, N.J., Oct. 14 /PRNewswire/ -- Prolong Pharmaceuticals today announced that the company has received a commitment of $30 million in funding from a private investor group. The monies ...

POMONA, Calif. –Prolong® Super Lubricants offers its industry-leading Engine Treatment and Booster System to protect gas and diesel engines from the two leading causes of engine wear: damaging ...

The Society for Maternal-Fetal (SMFM) released the following statement in response to the published results of "Progestin's Role in Optimizing Neonatal Gestation," more commonly referred to as the ...

SOUTH PLAINFIELD, N.J.--(BUSINESS WIRE)--Prolong Pharmaceuticals, LLC (the Company), a clinical-stage biopharmaceutical company, today announced that it will present key clinical data from HEMERA-1, ...